These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unexpected genomic rearrangements at targeted loci associated with CRISPR/Cas9-mediated knock-in. Rezza A; Jacquet C; Le Pillouer A; Lafarguette F; Ruptier C; Billandon M; Isnard Petit P; Trouttet S; Thiam K; Fraichard A; Chérifi Y Sci Rep; 2019 Mar; 9(1):3486. PubMed ID: 30837594 [TBL] [Abstract][Full Text] [Related]
5. Efficient gene-targeting in rat embryonic stem cells by CRISPR/Cas and generation of human kynurenine aminotransferase II (KAT II) knock-in rat. Yamamoto S; Ooshima Y; Nakata M; Yano T; Nishimura N; Nishigaki R; Satomi Y; Matsumoto H; Matsumoto Y; Takeyama M Transgenic Res; 2015 Dec; 24(6):991-1001. PubMed ID: 26454650 [TBL] [Abstract][Full Text] [Related]
6. Creating Knockin Alleles in Mouse Embryonic Stem Cells by CRISPR/Cas9-Mediated Homologous Recombination Without Drug Selection. Liu P; Li Y; Lei J; Dong L Methods Mol Biol; 2019; 1874():115-137. PubMed ID: 30353511 [TBL] [Abstract][Full Text] [Related]
7. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does. Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224 [TBL] [Abstract][Full Text] [Related]
8. Crispr/Cas9-mediated cleavages facilitate homologous recombination during genetic engineering of a large chromosomal region. Zhang F; Cheng D; Wang S; Zhu J Biotechnol Bioeng; 2020 Sep; 117(9):2816-2826. PubMed ID: 32449788 [TBL] [Abstract][Full Text] [Related]
9. A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines. Martin Gonzalez J; Baudet A; Abelechian S; Bonderup K; d'Altri T; Porse B; Brakebusch C; Juliusson G; Cammenga J Genesis; 2018 Sep; 56(9):e23238. PubMed ID: 30010246 [TBL] [Abstract][Full Text] [Related]
11. Optimized CRISPR-Cas9-based Strategy for Complex Gene Targeting in Murine Embryonic Stem Cells for Germline Transmission. O'Neill TJ; Krappmann D; Gewies A Bio Protoc; 2022 May; 12(10):e4423. PubMed ID: 35813027 [TBL] [Abstract][Full Text] [Related]
12. The CRISPR/Cas system can be used as nuclease for in planta gene targeting and as paired nickases for directed mutagenesis in Arabidopsis resulting in heritable progeny. Schiml S; Fauser F; Puchta H Plant J; 2014 Dec; 80(6):1139-50. PubMed ID: 25327456 [TBL] [Abstract][Full Text] [Related]
13. Efficient scarless genome editing in human pluripotent stem cells. Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872 [TBL] [Abstract][Full Text] [Related]
14. Gene Editing in Rat Embryonic Stem Cells to Produce In Vitro Models and In Vivo Reporters. Chen Y; Spitzer S; Agathou S; Karadottir RT; Smith A Stem Cell Reports; 2017 Oct; 9(4):1262-1274. PubMed ID: 29020614 [TBL] [Abstract][Full Text] [Related]
15. Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9. Zhang L; Jia R; Palange NJ; Satheka AC; Togo J; An Y; Humphrey M; Ban L; Ji Y; Jin H; Feng X; Zheng Y PLoS One; 2015; 10(3):e0120396. PubMed ID: 25803037 [TBL] [Abstract][Full Text] [Related]
16. Robust and efficient knock-in in embryonic stem cells and early-stage embryos of the common marmoset using the CRISPR-Cas9 system. Yoshimatsu S; Okahara J; Sone T; Takeda Y; Nakamura M; Sasaki E; Kishi N; Shiozawa S; Okano H Sci Rep; 2019 Feb; 9(1):1528. PubMed ID: 30728412 [TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9-mediated efficient directed mutagenesis and RAD51-dependent and RAD51-independent gene targeting in the moss Physcomitrella patens. Collonnier C; Epert A; Mara K; Maclot F; Guyon-Debast A; Charlot F; White C; Schaefer DG; Nogué F Plant Biotechnol J; 2017 Jan; 15(1):122-131. PubMed ID: 27368642 [TBL] [Abstract][Full Text] [Related]
19. Efficient in planta gene targeting in tomato using geminiviral replicons and the CRISPR/Cas9 system. Dahan-Meir T; Filler-Hayut S; Melamed-Bessudo C; Bocobza S; Czosnek H; Aharoni A; Levy AA Plant J; 2018 Jul; 95(1):5-16. PubMed ID: 29668111 [TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]